XML 17 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Net service revenue $ 399,262 $ 364,661
Cost of service, excluding depreciation and amortization 238,309 216,329
General and administrative expenses:    
Salaries and benefits 75,631 74,459
Non-cash compensation 4,044 3,874
Other 41,680 40,417
Depreciation and amortization 3,593 4,417
Operating expenses 363,257 339,496
Operating income 36,005 25,165
Other income (expense):    
Interest income 120 19
Interest expense (1,703) (1,068)
Equity in earnings (loss) from equity method investments 1,860 (106)
Miscellaneous, net 601 1,112
Total other income (expense), net 878 (43)
Income before income taxes 36,883 25,122
Income tax expense (9,563) (9,923)
Net income 27,320 15,199
Net income attributable to noncontrolling interests (161) (69)
Net income attributable to Amedisys, Inc. $ 27,159 $ 15,130
Basic earnings per common share:    
Net income attributable to Amedisys, Inc. common stockholders, basic (usd per share) $ 0.80 $ 0.45
Weighted average shares outstanding, basic (shares) 33,971 33,443
Diluted earnings per common share:    
Net income attributable to Amedisys, Inc. common stockholders, diluted (usd per share) $ 0.79 $ 0.44
Weighted average shares outstanding, diluted (shares) 34,592 34,073